A Rational Optimization Approach for the Development of a Multiplexed Lateral Flow Immunoassay: Detection of Nonepithelial Ovarian Cancer Markers in Human Serum
Advanced Science · 2026
DOI: 10.1002/advs.202523192 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Aida Abdelwahed und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Materials, Depart of Bioengineering and Institute of Biomedical Engineering, Imperial College London, London, UK. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Commission Horizon Europe Marie Skłodowska-Curie Actions, Engineering and Physical Sciences Research Council, Royal Academy of Engineering.
Abstract (Originalsprache)
With the rise of non‐communicable diseases, lateral flow immunoassays (LFIAs) are well‐positioned to address the demand for disease monitoring. We present the use of peroxidase‐mimicking platinum nanozyme conjugates targeting three ovarian germ cell tumor markers (alpha‐fetoprotein (AFP), human chorionic gonadotropin (HCG), and cancer antigen 125 (CA125)) in LFIA. A “design of experiments” (DoE) approach was used to optimize antibody–nanozyme conjugation, superseding conventional “one‐factor‐at‐a‐time” optimization strategies, which neglect factor‐to‐factor interactions obscuring identification of optimal conditions. Crucial to disease monitoring, assays must demonstrate limits of detection (LoD) within clinically defined ranges and produce quantitative readouts. We address limitations of typical LoD calculations, which assume homoscedastic variance across marker concentrations, presenting an alternative model and applying it to assess LFIA performance, subsequently demonstrating clinically relevant LoDs in human serum. To robustly derive marker concentrations from LFIA readouts, the model was coupled with the resolution molecular concentration and, using patient samples, validated against laboratory gold standard values. AFP and HCG assays align well with gold standard measurements, with sensitivities of 87.5% and 100%, and specificities of 98.3% and 100%, respectively. This work outlines a development pipeline of a patient sample validated semiquantitative LFIA, utilizing DoE for streamlined optimization and improving modeling approaches to quantify performance in a manner representative of assay function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Materials, Depart of Bioengineering and Institute of Biomedical Engineering, Imperial College London, London, UK.
- Department of Physiology, Anatomy and Genetics, Department of Engineering Science, and Kavli Institute For Nanoscience Discovery, University of Oxford, Oxford, UK.
- Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
- Department of Clinical Biochemistry, North West London Pathology, Imperial College Healthcare NHS Trust, Charing Cross Hospital, London, UK.
- Department of Chemical Engineering, University College London, London, UK.
- West London Gynaecological Cancer Centre, Hammersmith Hospital, Imperial College NHS Trust, London, UK.
ORCID-Profile: Molly M Stevens
Förderung
- European Commission Horizon Europe Marie Skłodowska-Curie Actions
- Engineering and Physical Sciences Research Council
- Royal Academy of Engineering
- Fundação para Ciência e Tecnologia
- Rosetrees Trust
- Imperial College London President's Scholarship
- Cancer Research UK
Zitieren
APA
Abdelwahed, A., Eskildsen, C. E., Panariello, L., Shamsabadi, A., Sadler, C. J., Wilkes, E. H., Galvanin, F., Cheng, Y., Carvalho, S., Saso, S., & Stevens, M. M. (2026). A Rational Optimization Approach for the Development of a Multiplexed Lateral Flow Immunoassay: Detection of Nonepithelial Ovarian Cancer Markers in Human Serum. Advanced Science. https://doi.org/10.1002/advs.202523192
Vancouver
Abdelwahed A, Eskildsen CE, Panariello L, Shamsabadi A, Sadler CJ, Wilkes EH, et al. A Rational Optimization Approach for the Development of a Multiplexed Lateral Flow Immunoassay: Detection of Nonepithelial Ovarian Cancer Markers in Human Serum. Advanced Science. 2026. doi:10.1002/advs.202523192
BibTeX
@article{Abdelwahed2026,
author = {Abdelwahed, Aida and Eskildsen, Carl E and Panariello, Luca and Shamsabadi, André and Sadler, Christy J and Wilkes, Edmund H and Galvanin, Federico and Cheng, Yuxi and Carvalho, Sara and Saso, Srdjan and Stevens, Molly M},
title = {A Rational Optimization Approach for the Development of a Multiplexed Lateral Flow Immunoassay: Detection of Nonepithelial Ovarian Cancer Markers in Human Serum},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.202523192}
}
EUVIMED